PEPGEN INC. Increase (Decrease) in Accounts Payable, Trade
PEPGEN INC. (PEPG) reported Increase (Decrease) in Accounts Payable, Trade of $229.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-06
- PEPGEN INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $412.00K.
- PEPGEN INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was -$183.00K, a 119.41% decline year-over-year.
- PEPGEN INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $36.00K.
- PEPGEN INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$86.00K.
- PEPGEN INC. increase (decrease) in accounts payable, trade for fiscal 2025 was -$935.00K, a 229.50% decline from fiscal 2024.
- PEPGEN INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $722.00K.
- PEPGEN INC. increase (decrease) in accounts payable, trade for fiscal 2023 was -$369.00K.
- PEPGEN INC. increase (decrease) in accounts payable, trade for fiscal 2022 was -$1.41M, a 156.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 3 month as first filed | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $229.00K 10-Q · filed 2026-08-06 | $265.00K derived: sum of 3 quarters · filed 2026-08-06 | $179.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$183.00K 10-Q · filed 2026-05-12 | -$147.00K derived: sum of 2 quarters · filed 2026-05-12 | -$233.00K derived: sum of 3 quarters · filed 2026-05-12 | -$2.06M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$50.00K derived: sum of 2 quarters · filed 2026-03-04 | -$1.88M derived: sum of 3 quarters · filed 2026-08-06 | -$935.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | -$86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.91M derived: sum of 2 quarters · filed 2026-08-06 | -$971.00K 10-Q · filed 2025-11-12 | -$5.17M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$885.00K 10-Q · filed 2026-08-06 | -$5.08M derived: sum of 3 quarters · filed 2026-08-06 | -$6.75M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $943.00K 10-Q · filed 2026-05-12 | -$3.25M derived: sum of 2 quarters · filed 2026-05-12 | -$4.92M derived: sum of 3 quarters · filed 2026-05-12 | $1.58M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$5.87M derived: sum of 2 quarters · filed 2026-03-04 | $634.00K derived: sum of 3 quarters · filed 2026-03-04 | $722.00K 10-K · filed 2026-03-04 | |
| 2024-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.83M derived: sum of 2 quarters · filed 2025-11-12 | $4.92M 10-Q · filed 2025-11-12 | $1.99M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.59M 10-Q · filed 2025-08-07 | $3.66M derived: sum of 3 quarters · filed 2025-08-07 | $5.92M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $88.00K 10-Q · filed 2025-05-08 | -$2.84M derived: sum of 2 quarters · filed 2025-05-08 | -$583.00K derived: sum of 3 quarters · filed 2025-05-08 | -$161.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | -$671.00K derived: sum of 2 quarters · filed 2025-02-24 | -$249.00K derived: sum of 3 quarters · filed 2025-02-24 | -$369.00K 10-K · filed 2025-02-24 | |
| 2023-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.68M derived: sum of 2 quarters · filed 2024-11-07 | $2.56M 10-Q · filed 2024-11-07 | -$675.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $422.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $302.00K 10-Q · filed 2024-08-08 | -$2.93M derived: sum of 3 quarters · filed 2024-08-08 | -$2.54M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$120.00K 10-Q · filed 2024-05-14 | -$3.36M derived: sum of 2 quarters · filed 2024-05-14 | -$2.96M derived: sum of 3 quarters · filed 2024-05-14 | $77.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$3.24M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | -$2.84M derived: sum of 2 quarters · filed 2024-03-29 | $197.00K derived: sum of 3 quarters · filed 2024-03-29 | -$1.41M 10-K/A · filed 2024-03-29 | |
| 2022-09-30 | $395.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.43M derived: sum of 2 quarters · filed 2023-11-08 | $1.83M 10-Q · filed 2023-11-08 | $4.32M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.43M 10-Q · filed 2023-08-08 | $3.92M derived: sum of 3 quarters · filed 2023-08-08 | $2.85M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$1.60M 10-Q · filed 2023-05-11 | -$1.57M 10-Q · filed 2022-06-16 | $882.00K derived: sum of 2 quarters · filed 2023-05-11 | -$193.00K derived: sum of 3 quarters · filed 2023-05-11 | $864.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.41M derived: sum of 2 quarters · filed 2023-03-23 | $2.47M derived: sum of 3 quarters · filed 2023-03-23 | $2.51M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$18.00K derived: sum of 2 quarters · filed 2022-11-10 | $24.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.10M 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $42.00K 10-Q · filed 2022-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |